Charles Brandes's position in Novartis AG is currently worth $30.7M. That's 0.27% of their equity portfolio (99th largest holding). The first Novartis AG trade was made in Q4 2020. Since then Charles Brandes bought shares ten more times and sold shares on eight occasions. The stake costed the investor $21.8M, netting the investor a gain of 41% so far.